Nicholas B Larson1, Elizabeth J Bell2, Paul A Decker3, Mindy Pike2, Christina L Wassel4, Michael Y Tsai5, James S Pankow6, Weihong Tang6, Naomi Q Hanson5, Kristine Alexander7, Neil A Zakai7, Mary Cushman7, Suzette J Bielinski2. 1. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. Electronic address: Larson.nicholas@mayo.edu. 2. Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 3. Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 4. Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA. 5. Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. 6. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA. 7. Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, VT, USA; Department of Medicine, University of Vermont, Burlington, VT, USA.
Abstract
BACKGROUND AND AIMS: ABO blood type is associated with cardiovascular disease, although the underlying mechanisms are presumed to be complex. While the relationship between non-O blood types and von Willebrand Factor (vWF) is well-established, associations with cellular adhesion molecules (CAMs) across diverse populations are understudied. METHODS: We genetically inferred ABO alleles for N = 6202 participants from the Multi-Ethnic Study of Atherosclerosis. Linear regression was used to evaluate associations between major ABO allele dosages and log-transformed measurements of vWF (N = 924), soluble E-selectin (sE-selectin, N = 925), soluble P-selectin (sP-selectin, N = 2392), and soluble ICAM-1 (sICAM-1, N = 2236) by race/ethnicity. RESULTS: For the selectins, the A1 allele was associated with significantly lower levels for all races/ethnicities, with each additional allele resulting in a 28-39% decrease in sE-selectin and 10-18% decrease in sP-selectin relative to Type O subjects. However, the A2 allele demonstrated effect heterogeneity across race/ethnicity for sE-selectin, with lower levels for non-Hispanic whites (p = 0.0011) but higher levels for Hispanics (p = 0.0021). We also identified elevated sP-selectin levels for B-allele carriers solely in Hispanic participants (p = 1.0E-04). ABO-by-race/ethnicity interactions were significant for both selectins (p < 0.0125). More modest associations were observed between A1 allele dosage and levels of sICAM-1, with ABO alleles explaining 0.8-1.1% of the total phenotypic variation within race/ethnicity. ABO associations with vWF activity were consistent across race/ethnicity, with B allele carriers corresponding to the highest vWF activity levels. CONCLUSIONS: ABO blood type demonstrates complex associations with endothelial markers that are largely generalizable across diverse populations.
BACKGROUND AND AIMS: ABO blood type is associated with cardiovascular disease, although the underlying mechanisms are presumed to be complex. While the relationship between non-O blood types and von Willebrand Factor (vWF) is well-established, associations with cellular adhesion molecules (CAMs) across diverse populations are understudied. METHODS: We genetically inferred ABO alleles for N = 6202 participants from the Multi-Ethnic Study of Atherosclerosis. Linear regression was used to evaluate associations between major ABO allele dosages and log-transformed measurements of vWF (N = 924), soluble E-selectin (sE-selectin, N = 925), soluble P-selectin (sP-selectin, N = 2392), and soluble ICAM-1 (sICAM-1, N = 2236) by race/ethnicity. RESULTS: For the selectins, the A1 allele was associated with significantly lower levels for all races/ethnicities, with each additional allele resulting in a 28-39% decrease in sE-selectin and 10-18% decrease in sP-selectin relative to Type O subjects. However, the A2 allele demonstrated effect heterogeneity across race/ethnicity for sE-selectin, with lower levels for non-Hispanic whites (p = 0.0011) but higher levels for Hispanics (p = 0.0021). We also identified elevated sP-selectin levels for B-allele carriers solely in Hispanic participants (p = 1.0E-04). ABO-by-race/ethnicity interactions were significant for both selectins (p < 0.0125). More modest associations were observed between A1 allele dosage and levels of sICAM-1, with ABO alleles explaining 0.8-1.1% of the total phenotypic variation within race/ethnicity. ABO associations with vWF activity were consistent across race/ethnicity, with B allele carriers corresponding to the highest vWF activity levels. CONCLUSIONS:ABO blood type demonstrates complex associations with endothelial markers that are largely generalizable across diverse populations.
Authors: Alkes L Price; Nick J Patterson; Robert M Plenge; Michael E Weinblatt; Nancy A Shadick; David Reich Journal: Nat Genet Date: 2006-07-23 Impact factor: 38.330
Authors: Suzette J Bielinski; Cecilia Berardi; Paul A Decker; Phillip S Kirsch; Nicholas B Larson; James S Pankow; Michele Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Christina L Wassel; Joseph F Polak; Michael Y Tsai Journal: Atherosclerosis Date: 2015-02-23 Impact factor: 5.162
Authors: P L Lutsey; M Cushman; L M Steffen; D Green; R G Barr; D Herrington; P Ouyang; A R Folsom Journal: J Thromb Haemost Date: 2006-09-26 Impact factor: 5.824
Authors: D S Lee; M G Larson; K L Lunetta; J Dupuis; J Rong; J F Keaney; I Lipinska; C T Baldwin; R S Vasan; E J Benjamin Journal: J Thromb Haemost Date: 2007-10-16 Impact factor: 5.824
Authors: K L Wiggins; N L Smith; N L Glazer; F R Rosendaal; S R Heckbert; B M Psaty; K M Rice; T Lumley Journal: J Thromb Haemost Date: 2008-11-25 Impact factor: 5.824
Authors: Andrew D Paterson; Maria F Lopes-Virella; Daryl Waggott; Andrew P Boright; S Mohsen Hosseini; Rickey E Carter; Enqing Shen; Lucia Mirea; Bhupinder Bharaj; Lei Sun; Shelley B Bull Journal: Arterioscler Thromb Vasc Biol Date: 2009-09-03 Impact factor: 8.311
Authors: Benjamin F Voight; Hyun Min Kang; Jun Ding; Cameron D Palmer; Carlo Sidore; Peter S Chines; Noël P Burtt; Christian Fuchsberger; Yanming Li; Jeanette Erdmann; Timothy M Frayling; Iris M Heid; Anne U Jackson; Toby Johnson; Tuomas O Kilpeläinen; Cecilia M Lindgren; Andrew P Morris; Inga Prokopenko; Joshua C Randall; Richa Saxena; Nicole Soranzo; Elizabeth K Speliotes; Tanya M Teslovich; Eleanor Wheeler; Jared Maguire; Melissa Parkin; Simon Potter; N William Rayner; Neil Robertson; Kathleen Stirrups; Wendy Winckler; Serena Sanna; Antonella Mulas; Ramaiah Nagaraja; Francesco Cucca; Inês Barroso; Panos Deloukas; Ruth J F Loos; Sekar Kathiresan; Patricia B Munroe; Christopher Newton-Cheh; Arne Pfeufer; Nilesh J Samani; Heribert Schunkert; Joel N Hirschhorn; David Altshuler; Mark I McCarthy; Gonçalo R Abecasis; Michael Boehnke Journal: PLoS Genet Date: 2012-08-02 Impact factor: 5.917
Authors: Mindy M Pike; Nicholas B Larson; Christina L Wassel; Kevin P Cohoon; Michael Y Tsai; James S Pankow; Naomi Q Hanson; Paul A Decker; Cecilia Berardi; Kristine S Alexander; Mary Cushman; Neil A Zakai; Suzette J Bielinski Journal: Thromb Res Date: 2017-02-24 Impact factor: 3.944
Authors: Linda M Polfus; Laura M Raffield; Marsha M Wheeler; Russell P Tracy; Leslie A Lange; Guillaume Lettre; Amanda Miller; Adolfo Correa; Russell P Bowler; Joshua C Bis; Shabnam Salimi; Nancy Swords Jenny; Nathan Pankratz; Biqi Wang; Michael H Preuss; Lisheng Zhou; Arden Moscati; Girish N Nadkarni; Ruth J F Loos; Xue Zhong; Bingshan Li; Jill M Johnsen; Deborah A Nickerson; Alex P Reiner; Paul L Auer Journal: Hum Mol Genet Date: 2019-02-01 Impact factor: 6.150
Authors: Chen Yao; George Chen; Ci Song; Joshua Keefe; Michael Mendelson; Tianxiao Huan; Benjamin B Sun; Annika Laser; Joseph C Maranville; Hongsheng Wu; Jennifer E Ho; Paul Courchesne; Asya Lyass; Martin G Larson; Christian Gieger; Johannes Graumann; Andrew D Johnson; John Danesh; Heiko Runz; Shih-Jen Hwang; Chunyu Liu; Adam S Butterworth; Karsten Suhre; Daniel Levy Journal: Nat Commun Date: 2018-08-15 Impact factor: 14.919
Authors: Saeed M Kabrah; Samer S Abuzerr; Mohammed A Baghdadi; Ahmed M Kabrah; Arwa F Flemban; Fayez S Bahwerth; Hamza M Assaggaf; Eisa A Alanazi; Abdullah A Alhifany; Sarah A Al-Shareef; Wesam H Alsabban; Anmar A Khan; Hissah Alzhrani; Layal K Jambi; Radi T Alsafi; Akhmed Aslam; Hebah M Kabrah; Ahmad O Babalghith; Amr J Halawani Journal: Medicine (Baltimore) Date: 2021-12-30 Impact factor: 1.889
Authors: Artika P Nath; Scott C Ritchie; Nastasiya F Grinberg; Howard Ho-Fung Tang; Qin Qin Huang; Shu Mei Teo; Ari V Ahola-Olli; Peter Würtz; Aki S Havulinna; Kristiina Santalahti; Niina Pitkänen; Terho Lehtimäki; Mika Kähönen; Leo-Pekka Lyytikäinen; Emma Raitoharju; Ilkka Seppälä; Antti-Pekka Sarin; Samuli Ripatti; Aarno Palotie; Markus Perola; Jorma S Viikari; Sirpa Jalkanen; Mikael Maksimow; Marko Salmi; Chris Wallace; Olli T Raitakari; Veikko Salomaa; Gad Abraham; Johannes Kettunen; Michael Inouye Journal: Am J Hum Genet Date: 2019-10-31 Impact factor: 11.025